A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects
Status:
Withdrawn
Trial end date:
2009-12-31
Target enrollment:
Participant gender:
Summary
This study (A7881006) is the first multiple dose study in moderate asthmatic subjects and
aims to determine the safety and efficacy of PF-00610355 when subjects take PF-00610355 on a
daily basis for 4 weeks in subjects maintained on inhaled corticosteroid.